Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Braftovi
Published 2 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, the FDA approves Braftovi for mutant metastatic colorectal cancer, Novo Nordisk and GSK announce major deal activity in a mergers and acquisitions roundup, and UK regulators confiscate thousands of doses of illegal weight-loss medicines.